Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
mRNA | ITGB1 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | POLD4 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
mRNA | LAMB2 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | REEP5 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | MCFD2 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | ROMO1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | UEVLD | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | TCTN3 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |